Fong's Score in the Era of Modern Perioperative Chemotherapy for Metastatic Colorectal Cancer: A Post Hoc Analysis of the GERCOR-MIROX Phase III Trial.

Fiche publication


Date publication

octobre 2019

Journal

Annals of surgical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr VERNEREY Dewi


Tous les auteurs :
Makhloufi S, Turpin A, El Amrani M, André T, Truant S, Bachet JB, Vernerey D, Hebbar M

Résumé

Despite improvement in colorectal liver metastasis (CLM) treatment, survival after liver surgery remains highly variable. Several clinicopathologic prognostic factors have been reported, but their validity in the era of more effective perioperative chemotherapy remains to be defined. The aim of this study is to analyze the prognostic factors associated with survival after CLM resection.

Référence

Ann. Surg. Oncol.. 2019 Oct 22;: